#ACR21 L20- Anti-IFN Ab Emapalumab for MAS/sJIA
⭐️⬆️IFN in models of HLH/MAS, neutralization may be helpful
⭐️Pilot study in 14 pts w inadequate response to high-dose IV GC
⭐️Ok to continue IL1i
▶️13/14 pts remission
▶️ SAEs: 1 CMV reactivation
https://t.co/cuM9LcEr4u @RheumNow https://t.co/USYGNtq4eC